President And Ceo
CurrentIt is truly an honor to be associated with the talented scientists of AmberGen whose mission is to transform clinical diagnostics and drug discovery. Founded in 1995 to commercialize pioneering photonic technology developed at Boston University’s Molecular Biophysics Laboratory and the Photonics Center, the company has continued to innovate by solving key problems that limit progress in medicine. AmberGen’s approach combines patented techniques in proteomics and light-based control of biomolecules